IDEA TO CLINIC Trademark
IDEA TO CLINIC is a USPTO trademark filed by NATIONAL RESILIENCE, LLC. Status: Pending.
Trademark Facts
| Mark | IDEA TO CLINIC |
|---|---|
| Serial Number | 98667074 |
| Status | Pending |
| Filing Date | 2024-07-25 |
| Mark Type | Word |
| Nice Classes | 040 (Material Treatment), 042 (Software & IT) |
| Owner | NATIONAL RESILIENCE, LLC |
| Attorney of Record | Susan M. Natland |
| Prosecution Events | 30 |
| Latest Event | EXRA on 2026-02-26 |
Goods & Services
Custom manufacturing of pharmaceuticals, biological preparations, chemical preparations, and reagents for others; biomanufacturing for others, namely, manufacturing of gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins using biological organisms in the manufacturing process; biomanufacturing platform for others in the nature of custom manufacturing, custom biomanufacturing manufacturing of gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins using biological organisms in the manufacturing process; consulting services in the field of manufacturing processes for pharmaceuticals, biological preparations, chemical preparations, gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins; custom processing and manufacture of vectors, cells and proteins for use in the field of biotechnology; Scientific research, development, and consulting services in the field of manufacturing processes for pharmaceuticals, biological preparations, chemical preparations, gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins; Scientific research in the field of genetic engineering; biotechnology research and development; scientific, pharmaceutical, and medical research services relating to biological treatment and bioproduction; provision of information in the field of scientific research and development of biopharmaceuticals that are manufactured using biological treatment and bioproduction platforms; development of new technology for others in the field of biotechnology, biomanufacturing, and pharmaceuticals; new product design services; biotechnology design services in the field of the creation of gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins; preparation of reports in the nature of providing information about scientific research in the field of biomanufacturing and manufacturing processes for pharmaceuticals, biological preparations, chemical preparations, gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and protein